Susan Molineaux Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Susan Molineaux.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Susan Molineaux. Susan Molineaux is Director in GERON CORP ($GERN) and PRESIDENT AND CEO in Calithera Biosciences, Inc. ($CALA) and Director in Theravance Biopharma, Inc. ($TBPH).
Latest Insider Trading Transactions of Susan Molineaux
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CALA, GERN, TBPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 1.39 | 83,000 | 115,370 | 83,000 | |
| Apr 29 2021 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Option Exercise | A | 20.35 | 6,000 | 122,100 | 6,000 | |
| Apr 29 2021 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 9,828 | 0 | 9,828 | 0 to 9.8 K |
| Jun 09 2020 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 1.54 | 83,000 | 127,820 | 83,000 | |
| Apr 30 2020 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Option Exercise | A | 30.14 | 6,000 | 180,840 | 6,000 | |
| Apr 30 2020 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 6,635 | 0 | 6,635 | 0 to 6.6 K |
| Jan 22 2020 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 7.41 | 400,000 | 2,964,000 | 400,000 | |
| Jun 27 2019 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | P | 3.88 | 51,600 | 200,208 | 457,188 | 405.6 K to 457.2 K (+12.72 %) |
| Jun 07 2019 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 1.38 | 70,000 | 96,600 | 70,000 | |
| May 02 2019 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Option Exercise | A | 23.85 | 6,000 | 143,100 | 6,000 | |
| May 02 2019 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 8,385 | 0 | 8,385 | 0 to 8.4 K |
| Feb 11 2019 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Gift | G | 0.00 | 12,986 | 0 | 395,588 | 408.6 K to 395.6 K (-3.18 %) |
| Jan 14 2019 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 4.64 | 390,000 | 1,809,600 | 390,000 | |
| Jan 02 2019 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 13,125 | 0 | 107,980 | 94.9 K to 108 K (+13.84 %) |
| Nov 16 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Gift | G | 0.00 | 6,476 | 0 | 408,574 | 415.1 K to 408.6 K (-1.56 %) |
| Sep 28 2018 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 7,457 | 0 | 94,855 | 87.4 K to 94.9 K (+8.53 %) |
| Jul 02 2018 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 3,827 | 0 | 87,398 | 83.6 K to 87.4 K (+4.58 %) |
| Jul 02 2018 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 3,827 | 0 | 87,398 | 83.6 K to 87.4 K (+4.58 %) |
| May 17 2018 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 3.43 | 70,000 | 240,100 | 70,000 | |
| May 03 2018 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
| May 03 2018 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 8,186 | 0 | 14,186 | 6 K to 14.2 K (+136.43 %) |
| Mar 30 2018 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 3,088 | 0 | 83,571 | 80.5 K to 83.6 K (+3.84 %) |
| Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 6,798 | 17,947 | 0 | |
| Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 26,992 | 71,259 | 9,729 | |
| Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 26,992 | 71,259 | 44,860 | 17.9 K to 44.9 K (+151.06 %) |
| Jan 16 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 8.60 | 200,000 | 1,720,000 | 200,000 | |
| Jan 02 2018 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 7,292 | 0 | 80,483 | 73.2 K to 80.5 K (+9.96 %) |
| Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 2,700 | 7,128 | 6,006 | |
| Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 6,502 | 6,242 | 0 | |
| Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 5,300 | 13,992 | 34,030 | |
| Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 7,568 | 7,265 | 0 | |
| Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 5,300 | 13,992 | 15,368 | 10.1 K to 15.4 K (+52.64 %) |
| Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.96 | 7,568 | 7,265 | 10,068 | 2.5 K to 10.1 K (+302.72 %) |
| Oct 02 2017 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 6,021 | 0 | 73,191 | 67.2 K to 73.2 K (+8.96 %) |
| Jun 30 2017 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 4,738 | 0 | 67,170 | 62.4 K to 67.2 K (+7.59 %) |
| May 18 2017 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
| May 10 2017 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 2.63 | 50,000 | 131,500 | 50,000 | |
| Mar 31 2017 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 5,782 | 0 | 62,432 | 56.7 K to 62.4 K (+10.21 %) |
| Jan 03 2017 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 6,341 | 0 | 56,650 | 50.3 K to 56.7 K (+12.60 %) |
| Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 4,749 | 12,537 | 9,498 | |
| Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 5,418 | 5,201 | 6,502 | |
| Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 15,627 | 41,255 | 42,021 | |
| Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 6,306 | 6,054 | 7,568 | |
| Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 15,627 | 41,255 | 23,810 | 8.2 K to 23.8 K (+190.97 %) |
| Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.96 | 6,306 | 6,054 | 8,183 | 1.9 K to 8.2 K (+335.96 %) |
| Dec 01 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 3.35 | 165,000 | 552,750 | 165,000 | |
| Oct 03 2016 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 5,808 | 0 | 50,309 | 44.5 K to 50.3 K (+13.05 %) |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 4,749 | 12,537 | 14,247 | |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 7,586 | 7,283 | 11,920 | |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 16,146 | 42,625 | 47,919 | |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 8,829 | 8,476 | 13,874 | |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.48 | 4,410 | 2,117 | 0 | |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 16,146 | 42,625 | 31,885 | 15.7 K to 31.9 K (+102.59 %) |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.96 | 8,829 | 8,476 | 15,739 | 6.9 K to 15.7 K (+127.77 %) |
| Jul 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.48 | 4,410 | 2,117 | 6,910 | 2.5 K to 6.9 K (+176.40 %) |
| Jul 01 2016 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 4,897 | 0 | 44,501 | 39.6 K to 44.5 K (+12.36 %) |
| May 19 2016 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 2.74 | 50,000 | 137,000 | 50,000 | |
| May 05 2016 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Apr 01 2016 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 4,495 | 0 | 39,604 | 35.1 K to 39.6 K (+12.80 %) |
| Jan 21 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 4.71 | 185,000 | 871,350 | 185,000 | |
| Jan 04 2016 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 2,712 | 0 | 35,109 | 32.4 K to 35.1 K (+8.37 %) |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 4,749 | 12,537 | 18,996 | |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 5,418 | 5,201 | 19,506 | |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 11,640 | 30,730 | 73,794 | |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 6,306 | 6,054 | 22,703 | |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.48 | 5,512 | 2,646 | 4,410 | |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.48 | 4,367 | 2,096 | 0 | |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 11,640 | 30,730 | 109,112 | 97.5 K to 109.1 K (+11.94 %) |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.96 | 6,306 | 6,054 | 97,472 | 91.2 K to 97.5 K (+6.92 %) |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.48 | 5,512 | 2,646 | 91,166 | 85.7 K to 91.2 K (+6.44 %) |
| Dec 23 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.48 | 4,367 | 2,096 | 85,654 | 81.3 K to 85.7 K (+5.37 %) |
| Oct 01 2015 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 4,755 | 0 | 32,397 | 27.6 K to 32.4 K (+17.20 %) |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 10,288 | 27,160 | 23,745 | |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 14,087 | 13,524 | 24,924 | |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 30,279 | 79,937 | 85,434 | |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 16,396 | 15,740 | 29,009 | |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.48 | 14,330 | 6,878 | 9,922 | |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.48 | 15,282 | 7,335 | 4,367 | |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 30,279 | 79,937 | 78,787 | 48.5 K to 78.8 K (+62.42 %) |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.96 | 16,396 | 15,740 | 48,508 | 32.1 K to 48.5 K (+51.06 %) |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.48 | 14,330 | 6,878 | 32,112 | 17.8 K to 32.1 K (+80.59 %) |
| Jul 15 2015 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.48 | 15,282 | 7,335 | 17,782 | 2.5 K to 17.8 K (+611.28 %) |
| Jul 01 2015 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 3,067 | 0 | 27,642 | 24.6 K to 27.6 K (+12.48 %) |
| May 19 2015 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 3.88 | 35,000 | 135,800 | 35,000 | |
| Apr 24 2015 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Option Exercise | A | 18.41 | 12,000 | 220,920 | 12,000 | |
| Apr 24 2015 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Apr 01 2015 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 3,481 | 0 | 24,575 | 21.1 K to 24.6 K (+16.50 %) |
| Jan 02 2015 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 4,038 | 0 | 21,094 | 17.1 K to 21.1 K (+23.67 %) |
| Jul 02 2014 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 4,089 | 0 | 17,056 | 13 K to 17.1 K (+31.53 %) |
| May 21 2014 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 1.94 | 35,000 | 67,900 | 35,000 | |
| Apr 02 2014 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 6,280 | 0 | 12,967 | 6.7 K to 13 K (+93.91 %) |
| Jan 03 2014 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 2,769 | 0 | 6,687 | 3.9 K to 6.7 K (+70.67 %) |
| Oct 01 2013 | GERN | GERON CORP | Molineaux Susan | Director | Grant | A | 0.00 | 3,918 | 0 | 3,918 | 0 to 3.9 K |
| May 24 2013 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 1.10 | 35,000 | 38,500 | 35,000 | |
| Sep 28 2012 | GERN | GERON CORP | Molineaux Susan | Director | Option Exercise | A | 1.72 | 70,000 | 120,050 | 70,000 |
Page: 1